(Chinese Journal of Clinical Research)


(Chinese Journal of Clinical Research)

Chin J Clin Res
Chin J Clin Res
当前所在位置:
More Topics
 
Lung cancer
[2025 Vol.38 No.3]

Application of anti-angiogenic therapy combined with other drugs in advanced non-small cell lung cancer

LU Haiyan,XIAO Xinyao,GUO Shunyao,ZHOU Yi,SHEN Hua 

Abstract: Angiogenesis plays a crucial role in the development of most solid tumours by delivering nutrients and oxygen to the tumour, and lung cancer, a highly vascular tumour. Over the past decade or so, inhibition of angiogenesis has ...

Chin J Clin Res,2025,38(3):329-334. [PDF]


  • Targeted therapy of common driver gene-positive non-small cell lung cancer

    ZHOU Fei, CHEN Yue, HU Shuyi, SHEN Bo, FANG Ying, ZHOU Guoren

    Chin J Clin Res,2025,38(3):335-338,344. [PDF]


  • Research progress of gut microbes in immunotherapy of non-small cell lung cancer

    LI Feiyang, CHEN Yue, LIU Ying, HU Shuyi, SHEN Bo, FANG Ying, ZHOU Guoren

    Chin J Clin Res,2025,38(3):339-344.  [PDF]



    • Selection of second-line treatment for extensive-stage small cell lung cancer

      HU Shuyi, CHEN Xi, WU Sirui, LI Feiyang, LIU Ying, SHEN Bo, FANG Ying, ZHOU Guoren

      Chin J Clin Res,2025,38(3):345-350. [PDF]


    • Predictive value of baseline levels and trends of lymphocytes and their subsets on the efficacy of

      immunotherapy for advanced non-small cell lung cancer

      ZHAO Tong, ZHU Tingting, CHEN Lei, ZHANG Weike 

      Chin J Clin Res,2025,38(3):351-355,365.  [PDF]


    • Analysis of screening results of high-risk population for lung cancer in Anqing rural area from 2018 to 2023

      WANG Yingying, JIANG Yeqian, LI Mingzhu, YU Yan, LI Qianbing 

      Chin J Clin Res,2025,38(3):356-360.  [PDF]


    • Effects of osimertinib targeted therapy on tumor markers and T lymphocyte subsets in elderly patients with

      advanced non-small cell lung cancer

      MI Ting, YANG Xue

      Chin J Clin Res,2025,38(3):361-365.  [PDF]


    • Effect of camrelizumab combined with platinum-containing dual-drug regimen in treatment of advanced 

      lung adenocarcinoma

      HANG Ye, SONG Jin, CHEN Jinzhong, MAO Yixiang 

      Chin J Clin Res,2025,38(3):366-370.   [PDF]


    • Efficacy of anlotinib + camrelizumab combined with radiotherapy in treatment of advanced non-small 

      cell lung cancer

      QIAN Hongxiang, HUANG Ying 

      Chin J Clin Res,2025,38(3):371-374. [PDF]


    • Relationship between T lymphocyte subsets and the efficacy of immunotherapy combined with  chemotherapy

      and stereotactic body radiotherapy in non-small cell lung cancer patients with brain metastases

      WANG Wenqing, WANG Xiujuan, HAN Rongbo, DING Hao 

      Chin J Clin Res,2025,38(3):375-378. [PDF]


    • Significance of albumin-to-alkaline phosphatase ratio in evaluating chemotherapy efficacy and prognosis 

      of advanced non-small cell lung cancer

      GAO Jinfeng,HU Ping 

      Chin J Clin Res,2025,38(3):379-382,388.  [PDF]